Taj Pharmaceuticals: Our commitment to clients in the spread of COVID-19

We Taj Pharmaceuticals are in the midst of challenging times, brought upon us due to the unimaginable spread of COVID-19. As we grapple with this difficult and ever evolving situation, we wanted to reach out to make sure that you are doing okay and in case you needed any help. It is hard to think of a business that is not impacted by this pandemic, the effects of which we will all continue to feel for a long time.

Considering the current situation across the globe wherein everyone is trying their best to tackle the Coronavirus pandemic, we understand that we aren’t insulated from any uncertainties too.

We, as an organisation, are doing our bit to ensure the safety and security of our employees, partners, etc. while ensuring that the work isn’t hampered.


As a firm, we have always placed the highest emphasis on delivering quality generics to all our clients, consistently. I want to take this opportunity to assure you that our professional commitments continue to occupy an important place for all of us at Taj Pharmaceuticals even as we steer our way through the crisis. Our Values of Care and Working Together come to fore in difficult times like these — we want to be responsible towards you, as well as our people and the larger society that we are a part of. As we strive to be cautious and safe, we request you all to consider conducting meetings online. Our teams will support you and will be there to make sure the work goes on. As we gear up to adapt to the changes and work with you,  your support would be highly appreciated.

We Taj Pharmaceuticals have put in place several measures that are helping us address this situation. Earlier this week, we announced that our people would work from home until further notice or unless there is a critical business need. We have also discontinued all international travel and physical meetings for the time being.

We Taj Pharma have been able to make this decision on the back of a robust infrastructure and processes that we have put in place over the past few years, which enable us to continue providing seamless service to our clients without the need to be physically present in office. Accordingly, we are also working with our clients to assess where our teams can be moved to a virtual working space.

Abhishek Kumar Singh - CEO Taj Pharmaceuticals Limited
Abhishek Kumar Singh – CEO Taj Pharmaceuticals Limited

I want to give you the confidence that we have tested our Business Continuity processes and at no time, do our clients need to be concerned about our ability to service them seamlessly.

In this difficult time, we have witnessed some heartening examples of enduring human spirit and this gives me the belief that together we will overcome this.

I thank you for your continued support and we at Taj Pharmaceuticals, assure our continued support to you and your teams as we together navigate these challenging times. Looking forward to work together and support each other to tackle this unfortunate situation and rebuild a safe, secure environment for all of us. Most importantly, we wish good health and safety for you and your family.

Take care and stay safe.

Warm regards,

Abhishek Kumar Singh
CEO| Taj Pharmaceuticals India

News and Update Related to Coronavirus pandemic COVID-19

India COVID-19 coronavirus by city and state

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Coronavirus FAQs Coronavirus in India: how the 2019-nCoV could impact the world’s second–most populated country Coronavirus-affected countries: Italy Middle East South Korea Japan Singapore Malaysia China USA UK Thailand Philippines Latest on India coronavirus (Covid-19) situation, followed by details on states, union territories and cities. For latest coronavirus news updates, jump to NCR, Punjab, Tamil Nadu, Haryana, Telangana, Rajasthan, Uttar Pradesh, Karnataka, Bihar, Ladakh, Jammu and Kashmir, Andhra Pradesh, Maharashtra, Odisha, Himachal Pradesh, Mizoram, Kerala.

{Taj Pharma India} How the coronavirus (COVID-19) test works

How does the PCR test look for the virus in swab samples? How long does it take? How many samples is India testing daily, and can it test more? If it can, why has it not scaled up yet?

Coronavirus in India: how the COVID-19 could impact the fast-growing economy

India reported the first confirmed case of the coronavirus infection on 30 January 2020 in the state of Kerala. The affected had a travel history from Wuhan, China.

Every country needs to take boldest actions to stop COVID-19

Every country needs to take boldest actions to stop COVID-19. Ladies and Gentlemen, we are holding this press briefing in an empty UN City building, as staff are now working remotely as a social distancing measure due to the coronavirus. The lives of millions of people in our region are undergoing radical change.  There is, quite simply, a new reality.  The role of public health services is understood.  The value of health workers is appreciated like never before.

Coronavirus outbreak shows Asia needs to step up infection preparation [Taj Pharma]

Region is safer after epidemic lessons but new diseases always arising. In early January, the World Health Organization was notified by China that 41 people in Wuhan, the country’s seventh most populous city, had been hospitalized with what appeared to be a mystery strain of pneumonia. Many were reported to be workers in or visitors to a live animal market.

Labels: Covid-19, COVID-19 treatments, COVID-19 tests, Coronavirus Cases in India, Coronavirus Latest updates, Coronavirus News, COVID-19 trials, Coronavirus treatments, COVID-19 treatments, COVID-19 clinical trials, coronavirus ongoing trials, Coronavirus breaking news, Coronavirus updates, Coronavirus new cases, coronavirus outbreak, COVID-19 coronavirus